期刊文献+

内皮素在肺间质纤维化发生发展中的作用 被引量:1

原文传递
导出
摘要 肺间质纤维化(idiopathic pulmonaryfibrosis)是一种致病原因复杂、发病机制不清、缺乏有效治疗手段的致命性弥漫性肺间质疾病,其发病率及病死率逐年增高,确诊后平均存活期为2—4年,5年生存率仅为30%-50%。多种损伤因素均可单独或联合作用于肺脏,导致肺脏损伤与修复平衡失调,成纤维细胞和(或)细胞外基质沉积过度,最终形成肺纤维化。
出处 《中国基层医药》 CAS 2010年第9期1279-1280,共2页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献22

  • 1Shi-Wen X,Denton CP,Dashwoud MR,et al.Fibmblast matrix gene expression and connective tissue remodeling:role of endothelin-1.J Invest Dermatol,2001,116(3):417-425.
  • 2Selman M,Thannickal VJ,Pardo A,et al.Idiopathic pulmonary fibrosis:pathogenesis and therapeutic approaches.Drugs,2004,4(3):405-430.
  • 3Yanagisawa M,Kurihara H,Kuri h ara S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature,1988,32 (6163):411-415.
  • 4Rubany GM,Polokoff MA.Three mature(21-residue) endothelin isoforms(ET-1,ET-2,ET-3) are encode in human.PharmacolRev,1994,46(3):325-415.
  • 5Tershita K,Kato S,Sata M,et al.Increased endiothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.Am J Respirologr,2006,11 (2):145.
  • 6Jain R,Shaul PW,Borok Z,et al.Endothelin-1 Induces Alveolar EMT Through ET-A-mediated Production of Transforming Growth Factor-β1.Am J Respir Cell Mol Biol,2007,37(1):38.
  • 7Tsujino K,Hirota S,Endo M,et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.Int J Radiat Oncol Biol Phys,2003,55 (1):110.
  • 8周华仕,张幸,洪长福.内皮素在肺纤维化发病机制中的作用[J].浙江省医学科学院学报,2004,15(1):35-39. 被引量:1
  • 9Kyaw M,Yoshizumi M,Tsuchiya K,et al.Antioxidants inhibil endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein(MAP) kinase and activator protein-1(AP-1) Biochem.Pharmacol,2002,(10):1521-1531.
  • 10Jozsef L,Khreiss T,Fournier A,et al.Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes.Br J Pharmacol,2002,135(5):1167-1174.

二级参考文献43

  • 1韩文阳,王文杰.特发性肺纤维化治疗药物的最新研究进展[J].医学综述,2006,12(8):497-499. 被引量:7
  • 2张雷杰,张本法.高压氧综合治疗系统性硬皮病10例[J].中华航海医学杂志,1996,3(4):243-243. 被引量:3
  • 3Coker RK, Laurent GJ. Anti - cytokine approaches in pulmonary fibrosis:bring factors in focus [J]. Thorax, 1997 ;52:294 - 296.
  • 4Coker RK, Laurent GJ. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention[A]. Walter EH, du Bois RM. Immunology and Management of Interstitial Lung Disease [ M ]. London: Chapman and Hall, 1995 : 19 - 36.
  • 5Smith RE,Strieter RM,Phan SH,et al. TNF and IL -6 mediate MIP - 1 alpha expression in bleomycin - induced lung injury[J]. J Leukoc Biol, 1998 ;64:528 - 536.
  • 6Szapiel SV, Elson NA,Fulmur JD, et al. Bleomycin - induced interstitial pulmonary disease in the nude,athymic mouse[J]. Am Rev Respir Dis, 1979 ; 120:893 - 897.
  • 7Madtes DK, Elson AL, Hackman RL, et al. Transforming growth factor - alpha deficiency reduced pulmonary fibrosis in transgenic mice [ J ]. Am J Respir Cell Mol Biol, 1999 ;20:924 - 934.
  • 8Sime P J, Marr RA, Gauldie D, et al. Tumor necrosis factor - alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor - beta 1 and myofibrosis blasts[ J]. Am J Pathol, 1998 ; 153:825 - 832.
  • 9Hoffman GS, Merkel PA, Brasington RD, et al. Anti - tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis [ J 1. Arthritis Rheum,2004 ; 50 : 2296 - 2304.
  • 10Dpugla WW, Ryu JH,Schroeder DR. Idiopathic pulmonary fibrosis : im2 pact of oxygen and colchcines, prednisone, or no therapy on survival [J] .Am J Respir Cirt Care Med,2000;161:1172 - 1178.

共引文献40

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部